A groundbreaking study by researchers at AIIMS has demonstrated significant anti-cancer properties in a combination of traditional Ayurvedic formulations with modern immunotherapy treatments.
The Phase 2 clinical trial showed a 35% improvement in treatment response rates among patients receiving the combined therapy compared to those on standard treatment alone. The research has been published in a leading international medical journal.